Search Results

Search Results

Research Study Search Results

Return to Search Form
  1. Neuroscience

      1. Brain Tumor

        1. An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF with Adjuvant Temozolomide in Patients with Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma (The “ACT IV” Study) John Henson, MD
        2. A Prospective, Multi-center Trial of NovoTTF-100A Together With Temozolomide Compared to Temozolomide Alone in Patients with Newly Diagnosed GBM John Henson, MD
        3. A Phase II Clinical Trial Evaluating DCVax®-Brain, Autologous Dendritic Cells Pulsed with Tumor Lysate Antigen for the Treatment of Glioblastoma Multiforme Greg Foltz, MD
      2. Brain Tumor /Neurosurgery

        1. The Comprehensive Neuro-Oncology Data Repository (CONDR): Prospective Collection of Clinical Tissue and Imaging Data for the Study of Patients with Brain Tumors. Sarah C. Jost, MD
      3. Craniotomy /Interventional

        1. Intravenous acetaminophen for craniotomy patients Arthur M. Lam, M.D.
      4. Epilepsy

        1. Tissue Procurement and Repository for Future Neuroscience Studies Ryder Gwinn, MD
        2. A combined FMRI and electrophysiological study of human sensory perception Jehuda P Sepkuty, MD
      5. Epilepsy /Genetic

        1. Protocol For Research of Genetic Epilepsy Marcio Sotero de Menezes, MD
      6. Movement Disorders

        1. A Pivotal Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects. Ryder Gwinn, MD
      7. Multiple Sclerosis

        1. JCV Antibody Program in patients with Relapsing MS and who are Receiving or Considering Treatment with Tysabri Lily Jung, MD
        3. Biogen 215MS201 SYNERGY study Peiqing Qian, MD
        4. A Phase 1 Randomized Study of MEDI-551 in Subjects with Relapsing Forms of Multiple Sclerosis James Bowen, MD
        5. A multicenter, randomized, double-blind, parallel-group, placebo-controlled variable treatment duration study evaluating the efficacy and safety of Siponimod (BAF312) in patients with secondary progressive multiple sclerosis James Bowen, MD
        6. A Double-Blind, Placebo-Controlled, Single Ascending Intravenous Infusion Study of rHIgM22 in Patients with Multiple Sclerosis. James Bowen, MD
        7. A 12-month, randomized, blinded study to compare the efficacy and safety of fingolimod 0.25 mg and 0.5 mg administered orally once daily with glatiramer acetate 20 mg administered subcutaneously once daily in patients with multiple sclerosis. Lily Jung Henson, MD
        8. 101MS402 TYGRIS - Tysabri Global Observational Program in Safety Lily Jung, MD
      8. Neuro-Ophthalmology

        1. Eli Lilly NAION Steven Hamilton, MD
      9. Neuro-Otology

        1. Electric-Acoustic System (EAS) Douglas D Backous, MD
      10. Spine

        1. The EMPOWER study: Eon Mini™ Study - Product Options for Wellness, Effectiveness, and Relief; A Multi-Centered Evaluation of Patients with Chronic Pain of the Trunk and/or Limbs using Paddle Lead(s). Ryder Gwinn, MD
        2. RELIEF - A Global Registry to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain Ryder Gwinn, MD
      11. Stroke

        1. MISTIE III - Treatment of intracerebral hemorrhage. David Newell, MD
        2. A Phase 2 Randomized, Controlled Study with a Phase 1 Safety Cohort testing ALD-401 Derived from Autologous Bone Marrow Delivered via Intracarotid Infusion in Subjects with Ischemic Stroke with Blinded Assessments. William Likosky, MD